Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling

Thrombospondin 1 and Vasoactive Agents Indirectly Alter Tumor Blood Flow

(2015) Jeff S. Isenberg et al.   NEOPLASIA

Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells

(2014) S. Matsumura et al.   JOURNAL OF IMMUNOLOGY

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

(2009) Siddhartha Jaiswal et al.   CELL

History and development of radiation-protective agents

(2009) Joseph F. Weiss et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Functions and molecular mechanisms of the CD47–SIRPα signalling pathway

(2009) Takashi Matozaki et al.   TRENDS IN CELL BIOLOGY

Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation Injury

(2008) Jeff S. Isenberg et al.   AMERICAN JOURNAL OF PATHOLOGY

Gene Silencing of CD47 and Antibody Ligation of Thrombospondin-1 Enhance Ischemic Tissue Survival in a Porcine Model

(2008) Jeff S. Isenberg et al.   ANNALS OF SURGERY

Cellular responses to reactive oxygen species-induced DNA damage and aging

(2008) Catharina Bertram et al.   BIOLOGICAL CHEMISTRY

CD47 on experimentally senescent murine RBCs inhibits phagocytosis following Fc  receptor-mediated but not scavenger receptor-mediated recognition by macrophages

(2008) M. Olsson et al.   BLOOD

Thrombospondin 1 Promotes Tumor Macrophage Recruitment and Enhances Tumor Cell Cytotoxicity of Differentiated U937 Cells

(2008) G. Martin-Manso et al.   CANCER RESEARCH

Hyperbaric oxygenation for tumour sensitisation to radiotherapy: A systematic review of randomised controlled trials

(2008) M. Bennett et al.   CANCER TREATMENT REVIEWS

Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses

(2008) Jeff S. Isenberg et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Treatment of liver ischemia–reperfusion injury by limiting thrombospondin-1/CD47 signaling

(2008) Jeff S. Isenberg et al.   SURGERY

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling

(2007) J. S. Isenberg et al.   BLOOD